Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuekangtong (ginkgo biloba leaf extract) injection for acute primary subjective tinnitus
ChiCTR2300070807Phase 4Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Dec 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ginkgo biloba leaf extract injection in tinnitus, sponsored by Beijing Tongren Hospital. Primary endpoint: Tinnitus Handicap Inventory (THI). Started Dec 2021; status: recruiting.
02
Drugs
ginkgo biloba leaf extract injection
03
Conditions
tinnitus
Beyond the preview
Go deeper on ChiCTR2300070807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070807.